Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination
Tomohiro Bando, Reoto Takei, Yoshikazu Mutoh, Hajime Sasano, Yasuhiko Yamano, Toshiki Yokoyama, Toshiaki Matsuda, Kensuke Kataoka, Tomoki Kimura, Yasuhiro Kondoh
Abstract
<b>Although the association between acute exacerbation of interstitial lung disease and vaccination is not yet clarified, this is the first case report describing the possibility that SARS-CoV-2 vaccination may trigger acute exacerbation</b> https://bit.ly/3tpu6Cz
Topics & Concepts
ExacerbationMedicineVaccinationPulmonary fibrosisInterstitial lung diseaseIdiopathic pulmonary fibrosisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyCoronavirus disease 2019 (COVID-19)LungDiseaseVirologyPathologyInfectious disease (medical specialty)Internal medicineInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisSarcoidosis and Beryllium Toxicity ResearchSARS-CoV-2 and COVID-19 Research